title: Acute Myeloid Leukemia Complicated by Giant Cell Arteritis.
abstract: Giant cell arteritis (GCA), a type of systemic arteritis, is rare in Japan. We herein report a case of acute myeloid leukemia (AML) complicated by GCA that manifested during chemotherapy for AML. A 77-year-old woman with severe back pain was diagnosed with AML. She achieved complete remission with the resolution of her back pain following induction chemotherapy. However, she developed a headache and fever after consolidation chemotherapy. A diagnosis of GCA was made based on a biopsy of the temporal artery and arterial imaging. GCA should therefore be included in the differential diagnosis in AML patients complicated with a headache and fever of unknown origin.
authors.affiliation: Department of Hematology, Shinko Hospital, Japan.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Tsunemine
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Umeda
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Nohda
authors.forename: Emiko
authors.initials: E
authors.lastname: Sakane
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Akasaka
authors.forename: Kiminari
authors.initials: K
authors.lastname: Itoh
authors.forename: Mayuko
authors.initials: M
authors.lastname: Izumi
authors.forename: Goh
authors.initials: G
authors.lastname: Tsuji
authors.forename: Taiichi
authors.initials: T
authors.lastname: Kodaka
authors.forename: Tomoo
authors.initials: T
authors.lastname: Itoh
authors.forename: Takayuki
authors.initials: T
authors.lastname: Takahashi
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001416:Back Pain / Q000209:etiology*; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D013700:Giant Cell Arteritis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007564:Japan; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D012074:Remission Induction; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D011239:Prednisolone